A safe purchase depends on more than finding a catalogue listing for denosumab. You will be able to identify the exact presentation, test whether a quotation is legally and commercially usable in Bolivia, and verify the shipment before it reaches a patient.
Key takeaways
- Request denosumab, 60 mg in 1 mL, as a single-use pre-filled syringe.
- Require documented refrigerated handling and temperature records with every quotation.
- Check Bolivia registration, import authorisation, invoice and transport documents before dispatch.
- Define delivery responsibility, temperature-risk ownership and quarantine procedures in writing.
How to identify the exact Prolia item before requesting a quote
Ask for the supplier’s catalogue ID for PROLIA 60MG and written confirmation that the item is available for a current quotation, not merely listed in a catalogue. Specify Prolia 60 mg (denosumab), a single-use 1 mL pre-filled syringe for subcutaneous administration, with a six-month dosing schedule.
State whether the quotation covers the originator Prolia brand or a denosumab biosimilar. A denosumab pharmaceutical supplier is not automatically a prolia 60 mg wholesale supplier.
- Require the manufacturer, marketing-authorisation holder, country of origin, manufacturing site, Bolivian registered product name, sanitary-registration number and approved indication.
- Ask for the allocated batch number, manufacturing date, expiry date and batch-specific certificate of analysis.
- If no batch is allocated, mark those records as pending. Do not treat a catalogue description as evidence.
- Reject the assumption that a foreign manufacturing licence, export certificate or generic GMP statement proves authorisation for sale in Bolivia.
| Option | Identification to confirm | Procurement decision |
|---|---|---|
| Originator Prolia | Registered Prolia brand, 60 mg in a 1 mL pre-filled syringe, matching prescribing information | Quote only if the catalogue ID and current stock are confirmed |
| Authorised denosumab biosimilar | Different registered name, manufacturer and marketing-authorisation holder, with the same approved indication, strength and device verified in Bolivia | Compare only after registration and prescribing information are confirmed |
| Other denosumab product | Different vial, concentration, device, indication or investigational status | Do not treat it as the requested item |
The quoted product must match the registered brand or authorised biosimilar, device, strength, indication and prescribing information. A prolia 60 mg pharmaceutical supplier in sucre should identify those details before pricing.
What presentation and cold-chain evidence should accompany the quotation
The quotation must identify a single-use 60 mg solution in a 1 mL pre-filled syringe, not merely “denosumab.” Ask the Prolia 60 mg wholesale supplier or denosumab injection supplier in Sucre to confirm the pack size, syringes per carton, carton configuration, labelled storage instructions and that the syringe will not be diluted or mixed with another medicine.
| Quote item | Evidence to request | Reject or clarify |
|---|---|---|
| Presentation | 1 mL pre-filled syringe, 60 mg, single use; pack and carton quantities | Vial, different concentration, diluted product, raw material or investigational product |
| Storage | Label showing 2°C to 8°C; original carton for light protection; “do not freeze” and “do not shake” | Unlabelled or ordinary ambient parcel packaging |
| Transport | Qualified refrigerated packaging, temperature logger or equivalent, dispatch and delivery temperatures | No monitor, validation evidence or temperature record |
| Excursion control | Written procedure naming the reviewer and replacement payer if temperature leaves range | Supplier leaves acceptance and loss allocation undefined |
The EMA product information allows storage up to 25°C for up to 30 days; once removed from refrigeration, Prolia must not return to the refrigerator. That allowance does not validate an uncontrolled ambient shipment.
- Require the supplier to state whether the logger covers packing, transit, customs delay and delivery in Sucre.
- Compare the complete cold-chain service, including qualified packaging, monitoring, replacement terms and wastage risk, rather than the medicine price alone.
Which Bolivian approvals and shipping documents must be checked
A supplier cannot release Prolia in Bolivia merely because an Indian exporter holds an export certificate.
For prolia procurement options in Sucre, establish in writing whether the seller exports only or supports importation and delivery into Bolivia, including AGEMED sanitary registration or import authorisation, importer and distributor licensing, customs clearance, import permits, local release and delivery to Sucre.
Before payment, obtain the product’s Bolivian registration or authorisation and the supplier’s or importer’s authorization, then verify both with AGEMED.
| Route | Who handles the legal route | Evidence to require |
|---|---|---|
| Export only | Buyer appoints the Bolivian importer and handles release | Written exclusion of customs, AGEMED and local-delivery responsibility |
| Import-supported | Supplier or named importer coordinates registration, permits, clearance and delivery | Verified authorizations, named importer and written allocation of liability |
For the quoted batch, separate records already available from promises:
- Already available: commercial invoice, packing list, certificate of analysis, certificate of pharmaceutical product, certificate of origin, lot number, manufacturing date, expiry date, batch-release documentation and complete cold-chain records.
- Promised later: documents unavailable because no batch is allocated, with a stated delivery date and condition before dispatch.
A prolia 60 mg pharmaceutical supplier in Sucre must also state the Incoterm, named delivery point, transport route, minimum order quantity, case quantity, lead time, payment terms, insurance and responsibility for customs delays. Calculate landed cost using refrigerated transport, import work, local distribution, excursion-related wastage and pharmacovigilance obligations—not the unit price alone.
How to compare supplier quotations and delivery responsibilities
Compare every Prolia procurement option in one written schedule, not by unit price. Use this table for each candidate, including NIBA HEALTHCARE if it is being assessed as a Prolia 60 mg pharmaceutical supplier in Sucre.
| Option | Originator or biosimilar; manufacturer; marketing-authorisation holder | Registered presentation | Batch; shelf life | MOQ; case quantity | Lead time; repeat supply at six months | Incoterm; payment | Freight method | Landed cost in Sucre |
|---|---|---|---|---|---|---|---|---|
| Candidate A | State brand status, companies and country | 60 mg/1 mL pre-filled syringe; registered name | Batch number; expiry; months remaining | Units; cartons | Days; confirm next-dose availability | Named term; deposit or credit | Validated refrigerated freight | Product, freight, customs, AGEMED, local delivery and wastage |
| Candidate B | State brand status, companies and country | Exact registered device and pack | Batch number; expiry; months remaining | Units; cartons | Days; six-month replenishment plan | Named term; deposit or credit | Logger-monitored cold chain | Same cost basis |
Ask whether the seller is an exporter only or will coordinate a Bolivian importer, AGEMED requirements, customs clearance and local release. Require a batch-specific certificate of analysis, certificate of origin, release records and temperature data; a generic GMP claim or ordinary parcel delivery is incomplete.
For a denosumab pharmaceutical supplier, identify the pharmacist or quality contact responsible for recalls, suspected falsification, excursions and adverse-event escalation. Include insurance and excursion replacement in landed cost. A low first order is unusable if the next dose cannot arrive on schedule.
Requesting this information from NIBA HEALTHCARE in one batch-specific quotation separates a catalogue listing from a procurement-ready offer.
Related product
![]() | DENOSUMAB INJECTION Prolia Solution for Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. View product → |
How to authenticate and quarantine the shipment on receipt
Release the shipment only after the receiving pharmacist or quality unit verifies the product, documents and cold chain. Apply this standard to every denosumab injection supplier in Sucre and compare Prolia procurement options on evidence, not a catalogue entry.
1. Match Prolia or the approved biosimilar name, 60 mg strength, 1 mL pre-filled syringe format, manufacturer, marketing-authorisation holder, country of origin, batch or lot number and expiry date against the purchase order, invoice, batch-specific certificate of analysis and registration record.
2. Inspect the outer carton, syringe and tamper evidence. Look for crushed packaging, leaks, altered labels, missing seals, inconsistent language or an incorrect device. Check serialisation or another security feature when the registered pack uses one.
3. Reconcile the temperature logger report with dispatch, transit and delivery times. An intact carton does not prove an acceptable cold chain; frozen exposure or an unexplained excursion requires assessment before release.
4. Quarantine any shipment with damaged packaging, mismatched lot details, missing batch documents or unverifiable serialisation. Keep suspected falsified product out of stock and escalate it to the responsible pharmacist or quality unit; do not return it to inventory.
5. Before administration, confirm that pre-existing hypocalcaemia is corrected and that clinical teams address calcium and vitamin D guidance. Flag the higher hypocalcaemia risk in severe renal impairment or dialysis.
Record the six-month dose date. If a dose is missed or Prolia is discontinued, the prescriber must follow the product information, including transition to an alternative antiresorptive when indicated.
Frequently asked questions
How do you identify the exact Prolia item before requesting a quote?
Specify Prolia 60 mg (denosumab), a single-use 1 mL pre-filled syringe for subcutaneous administration, with a six-month dosing schedule. Ask for the supplier’s catalogue ID and written confirmation that stock is available for the current quotation.
What presentation and cold-chain evidence should accompany a Prolia quotation?
Request the presentation, batch information, expiry date and storage instructions, along with evidence of refrigerated handling. Ask who records temperatures, which packaging protects the shipment, and what happens if the temperature record shows an excursion.
Which Bolivian approvals and shipping documents must be checked?
Confirm the product’s Bolivian registration status with the responsible health authority and verify the supplier’s authority to export or distribute it. Check the commercial invoice, packing list, transport document, batch and expiry details, and any import or customs documents required for the shipment.
How should healthcare buyers compare Prolia supplier quotations?
Compare the price per syringe, minimum order, expiry remaining, lead time, freight, insurance, cold-chain packaging, taxes and customs charges. Record whether the supplier or buyer carries responsibility for temperature excursions, delays, loss and customs clearance.
How do you authenticate and quarantine Prolia on receipt?
Keep the shipment in quarantine until you check the seal, label, 60 mg strength, 1 mL presentation, batch number, expiry date, packaging condition and temperature record. Do not release a damaged pack or a shipment with an unexplained temperature excursion until your pharmacist or quality team investigates it.
